trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
Published 3 years ago • 1.5K plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
6:51
adcs for her2 and her2-low breast cancer
-
1:36
is her2-low a distinct subtype of breast cancer?
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:16
her2-low expression in breast cancer
-
1:24
novel treatment options for her2-low breast cancer
-
1:09
the exciting new field of her2-low breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
2:05
latest news in her2-low breast cancer
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
3:31
her2-low mbc patients report preserved qol with trastuzumab deruxtecan
-
8:42
trastuzumab deruxtecan in her2 breast cancer